Stock Chart
SLNO
Type: SELL growth_1yr
Strike: $35
Premium: $9.50
Expiry: Jan 15, 2027
Target: $30
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About SLNO - Soleno Therapeutics, Inc. Common Stock
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
Key Statistics
More SLNO Analysis
This SLNO stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track SLNO's price movements with trendlines, gamma walls, and key support/resistance levels.